VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BTSG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BTSGBrightSpring Health Services, Inc. Common Stock
$68.98$13.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBTSGCash Flow

BrightSpring Health Services, Inc. Common Stock (BTSG) Cash Flow Statement

7Y historyFree accessUpdated daily

While capital expenditures remain low at approximately 0.7% of revenue, cash flow volatility persists, as evidenced by the OCF/NI ratio swinging from -24.84 in 2023Q4 to 0.83 in 2026Q1.

BTSG Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Cash from Operations511.51M490.17M23.77M210.78M-4.65M270.17M222.64M110.91M
Operating CF Margin %-3.8%0.21%2.39%-0.06%4.03%3.99%2.45%
Operating CF Growth %895.05%1961.79%-88.72%4630.05%-101.72%21.35%100.74%-
Net Income309.89M190.67M-20.52M-156.84M-54.22M51.26M21.15M-71.09M
Depreciation & Amortization161.21M164.28M204.48M202.34M203.97M199.16M181.5M154.87M
Stock-Based Compensation58.09M70.1M69.17M3.92M3.55M4.52M6.27M3.71M
Deferred Taxes-4.03M0-25.91M-52.63M-27.96M6.49M22.6M-34.41M
Other Non-Cash Items-600K83.67M66.63M54.56M94.48M38.85M27.2M64.31M
Working Capital Changes-13.43M-18.54M-270.07M159.44M-224.47M-30.11M-36.08M-6.48M
Change in Receivables-165.96M-131.29M-179.04M-127.25M-150.47M-93M-58.91M-53.95M
Change in Inventory-26.37M-177.91M-236.51M28.66M-131.83M4.29M-95.73M-16.03M
Change in Payables231.06M264.17M303.21M105.65M133.47M63.54M100.43M46.78M
Cash from Investing466.5M-310.18M-140.24M-134.43M45.36M-1.19B-452.87M-1.53B
Capital Expenditures-3.91M0-80.91M-73.53M-70.11M-59.27M-51.91M-51.22M
CapEx % of Revenue0.03%0.74%0.72%0.83%0.91%0.88%0.93%1.13%
Acquisitions-35.45M0-59.8M-63.06M113.33M-1.13B-402.01M-1.48B
Investments--------
Other Investing505.87M-310.18M473K2.15M2.13M1.7M1.05M1.41M
Cash from Financing-141.86M-152.77M164.65M-76.91M-73.81M705.22M473.94M1.41B
Debt Issued (Net)78.5M-127.12M-829.36M-66.14M-68.93M726.86M493.17M1.27B
Equity Issued (Net)-32.57M-17.89M1.04B-650K012.39M-1.12M261.14M
Dividends Paid00000000
Share Repurchases-103.17M-43.17M-650K-650K0-417K-1.12M-12.29M
Other Financing-187.79M-7.75M-50.83M-10.12M-4.88M-34.03M-18.11M-118.59M
Net Change in Cash837M27.12M48.18M-557K-33.11M-215.27M243.71M-12.23M
Free Cash Flow507.6M394.69M-57.14M137.26M-74.77M210.9M170.73M59.69M
FCF Margin %3.72%3.06%-0.51%1.56%-0.97%3.15%3.06%1.32%
FCF Growth %298.11%790.75%-141.63%283.58%-135.45%23.52%186.03%-
FCF per Share2.291.80-0.300.80-0.441.231.000.35
FCF Conversion (FCF/Net Income)1.64x2.57x-1.32x-1.36x0.09x5.43x10.70x-1.53x
Interest Paid-53.8M183.51M211.39M303.53M213.31M126.95M129.57M134.38M
Taxes Paid-245K26.97M24.95M37.5M28.85M03M3.72M

Key Metrics

Growth RegimeExpanding
ProfitabilityStrained
Balance SheetMixed
Cash FlowMixed
Top Statement Risk

Working capital volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Remains Highly Variable

As reported in recent financial statements, the relationship between net income and operating cash flow is inconsistent, with the OCF/NI ratio fluctuating wildly from -24.84 in 2023Q4 to 5.66 in 2024Q4, indicating that GAAP earnings are currently poor proxies for the company's actual cash-generative capacity.

The significant divergence between net income and operating cash flow suggests that non-cash charges and working capital swings are heavily distorting the bottom line. Investors should monitor whether this volatility is a structural byproduct of Medicaid billing cycles or indicative of underlying accounting adjustments that mask operational cash flow stability.

Working Capital Swings Impede Liquidity

Based on the provided cash flow data, working capital changes have been a major source of volatility, ranging from a $121.9 million inflow in 2023Q4 to a $99.9 million outflow in 2024Q1, highlighting the sensitivity of the company's cash position to the timing of government reimbursement receipts.

The erratic nature of these working capital movements suggests that the company's cash flow is highly susceptible to administrative delays in the Medicaid and Medicare billing process. This lack of predictability in cash conversion cycles may necessitate higher liquidity buffers than the current balance sheet might otherwise suggest.

Capital Intensity Remains Structurally Low

According to the company's quarterly filings, capital expenditures as a percentage of revenue have remained consistently low, averaging approximately 0.7% over the last ten quarters, which suggests that the business model is not capital-intensive in terms of physical asset maintenance or infrastructure replacement requirements.

The low capital intensity implies that the company's primary growth engine is inorganic acquisition rather than internal capacity expansion. While this preserves cash, it also suggests that the firm's competitive moat is not built on proprietary physical infrastructure, but rather on the integration of acquired service networks.

Aggressive Capital Allocation Strategy Observed

As evidenced by the recent cash flow data, the company has prioritized significant capital deployment toward share repurchases, including a $60.0 million outflow in 2026Q1, alongside ongoing net acquisition activity, which collectively compete with the firm's ability to retain cash for deleveraging or operational contingencies.

The decision to allocate substantial cash to share repurchases while operating with thin net margins warrants further investigation into management's long-term capital priorities. This strategy appears to favor immediate shareholder returns over building a more robust cash cushion to mitigate the inherent risks of the healthcare services sector.

BTSG — Frequently Asked Questions

Quick answers to the most common questions about buying BTSG stock.

How much cash does BrightSpring Health Services, Inc. Common Stock (BTSG) generate from operations?

BrightSpring Health Services, Inc. Common Stock (BTSG) generated $490.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is BrightSpring Health Services, Inc. Common Stock's free cash flow?

BrightSpring Health Services, Inc. Common Stock (BTSG) generated $394.7M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is BrightSpring Health Services, Inc. Common Stock's capital expenditure (CapEx)?

BrightSpring Health Services, Inc. Common Stock (BTSG) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does BrightSpring Health Services, Inc. Common Stock distribute cash to shareholders?

In 2025, BrightSpring Health Services, Inc. Common Stock (BTSG) spent $43.2M on share repurchases. This shows the company's commitment to returning capital to its equity investors.